After all, having a full stomach or uncomfortable symptoms after eating can make you feel sluggish, low-energy, and impact how you feel in social situations involving food
Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist, while Tirzepatide (Mounjaro, Zepbound) binds with both receptors (GLP-1 and GIP) and thus tends to have more effects on weight loss than semaglutide alone
JAMA Ophthalmol [Internet]
T.KummerM
Some patients also want to compare injectable options with oral therapies before deciding what to discuss with a clinician
J Biol Chem 250:61346140 Chen H, Tsalkova T, Chepurny OG, Mei FC, Holz GG, Cheng X, Zhou J (2013) Identification and characterization of small molecules as potent and specific EPAC2 antagonists